Europe Cryochambers Market Research focuses on the key trends prevailing in the Europe Cryochambers Industry sector. The existing Industry scenario has been studied and future projections with respect to the sector have also been investigated. Market study report comprises evaluation of numerous influential factors including industry overview in terms of historic and present situation, key manufacturers, product/service application and types, key regions and marketplaces, forecast estimation for global market share, revenue and CAGR.
𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/3628
Cryotherapy is an advanced procedure that utilizes a method of localized freezing temperatures to deaden an irritated nerve. It is used in the treatment of localized areas of some cancers and in diseases related to skin.
Cryochambers are units, which use liquid nitrogen, liquid synthetic air or cooling units for cryogenic application.
Europe cryochambers market is estimated to account for US$ 53.1 Mn in terms of value in 2019 and is expected to reach US$ 76.5 Mn by the end of 2027.
Europe Cryochambers Market: Drivers
Increasing application of cryotherapy is projected to augment growth of Europe cryochambers market over the forecast period. For instance, cryotherapy can be used in the treatment of migraines, nerve irritation, mood disorders, arthritic pain, low-risk tumors, dementia and Alzheimer’s disease, and atopic dermatitis and other skin conditions.
Additionally, growing adoption of cryotherapy by athletes is again expected to support growth of the market. For instance, in February 2020, RANGERS FC, a Scottish professional football club, chose CryoAction as its official cryotherapy supplier for the Scottish Premier League.
Poland held dominant position in Europe cryochambers market in 2018, accounting for 18.0% share in terms of value, followed by 2027.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-pdf/3628
Europe Cryochambers Market: Restraints
Confliction in evidence to safety and efficacy of cryotherapy is projected to restrict growth of Europe cryochambers market. There is limited evidence regarding the safety and efficacy of cryotherapy. Claims for the application of cryotherapy in weight loss, sleep disorders, depression stress & anxiety, Alzheimer’s disease, migraines, and fibromyalgia are unsupported owing to lack of sufficient data to prove the efficacy of the therapy.
Additionally, lack of fully evolved regulatory pathway is again expected to hinder the market growth. Regulatory pathways for the approval of whole body cryotherapy chambers are not yet developed in Europe, which primarily restricts the widespread use of these devices.
Europe Cryochambers Market: Opportunities
Growing incidence of sports injuries is projected to provide a lucrative growth opportunities for players in the market. For instance, in November 2018, the study, ‘Results on sports-related injuries in children from NHS emergency care dataset Oxfordshire pilot: an ecological study’, children aged between 0–19 years accounted for 47.4% of sports injury-related emergency department attendances and around 23.5% of sports injury-related admissions for all ages.
Use of liquefied gases such as oxygen, nitrogen, and carbon dioxide require periodic refilling or replacement of gas cylinders. Thus, producers may focus on manufacturing cryotherapy devices that can use surrounding air as a cooling agent.
Cryochambers segment in Europe cryochambers market was valued at US$ 31.3 Mn in 2018 and is expected to reach US$ 49.4 Mn by 2027 at a CAGR of 5.4% during the forecast period.
Market Trends/Key Takeaways
Majority of the players in the market are offering mobile cryotherapy services to end users such as sports clubs and hospitals. For instance, BOC offers fully mobile whole-body cryotherapy chambers in the U.K.
Cryotherapy can be used to reduce cellular inflammatory infiltrate and fibrosis. Moreover, spray cryotherapy can be used to treat edema, inflammation, and goblet cell hyperplasia.
Europe Cryochambers Market: Competitive Landscape
Major players in Europe cryochambers include, Zimmer MedizinSysteme GmbH, KrioSystem Sp. z.o.o, Air Products and Chemicals, Inc., CSA Medical, Inc., METRUM CRYOFLEX Sp. z o.o., Sp. K., Novotech S.R.O, CryoAction Limited, JUKA SP. Z.O.O. SP.K., Cryosense, and CRYO Science.
Europe Cryochambers Market: Key Developments
Major players are focused on product approval and launch to expand their product portfolio. For instance, in December 2019, CSA Medical, Inc. received CE Mark approval for its RejuvenAir System, which applies metered cryospray of liquid nitrogen, for the treatment of chronic obstructive pulmonary disease with chronic bronchitis.
Major players are also focused on adopting partnership strategies to expand their product portfolio. For instance, in November 2019, iCRYO Cryotherapy, a cryotherapy franchise, partnered with CRYO Science. Under the partnership, CRYO Science will manufacture iCRYO Cryotherapy’s cryotherapy chambers.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 (Flat USD 2000 OFF)@ https://www.coherentmarketinsights.com/promo/buynow/3628
𝐀𝐛𝐨𝐮𝐭 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.